GRANTS RECEIVABLE |
12 Months Ended |
|---|---|
Dec. 31, 2022 | |
| Receivables [Abstract] | |
| GRANTS RECEIVABLE | GRANTS RECEIVABLEGrants receivable represents qualifying costs incurred where there is reasonable assurance that conditions of the grant have been met but the corresponding funds have not been received as of the reporting date. Grants receivable balances were $1.6 million as of December 31, 2022 and December 31, 2021, respectively. Grant receivables are classified as current or non-current receivables based on the Company’s best estimate of whether or not the amounts will be collected within one year of the balance sheet date. The Company received $1.5 million from the Cancer Prevention and Research Institute of Texas on February 15, 2023. |